These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7692197)

  • 1. Persistence of HCV despite antibodies to both putative envelope glycoproteins.
    Chien DY; Choo QL; Ralston R; Spaete R; Tong M; Houghton M; Kuo G
    Lancet; 1993 Oct; 342(8876):933. PubMed ID: 7692197
    [No Abstract]   [Full Text] [Related]  

  • 2. Low prevalence of anti-HCV antibodies in hospital workers.
    Stellini R; Calzini AS; Gussago A; Rodella A; Signorini A
    Eur J Epidemiol; 1993 Nov; 9(6):674-5. PubMed ID: 7512052
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis C core antibody detection in acute hepatitis and cirrhosis patients from Tunisia.
    Coursaget P; Simpson B; el Goulli N; Ben Khelifa H; Kastally R
    Pathol Biol (Paris); 1992 Jun; 40(6):646-8. PubMed ID: 1383914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sporadic vs. posttransfusion hepatitis C: why the differences?
    Achord JL
    Gastroenterology; 1991 Oct; 101(4):1133-4. PubMed ID: 1716237
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-HCV reactivity in dialysis patients: discrepancies between first and second generation tests.
    Beccari M; Sorgato G; Rizzolo L; Veneroni G
    Nephron; 1993; 63(2):238. PubMed ID: 7680775
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation between ELISA and recombinant immunoblot assay in serum samples positive for anti-HCV.
    Lin HH; Hsu HY; Chang MH; Wang JT; Chen PJ; Chen DS
    J Formos Med Assoc; 1992 Jul; 91(7):729-30. PubMed ID: 1360305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Specific antibody assay for genotyping of hepatitis C virus].
    Kohara M
    Nihon Rinsho; 1994 Jul; 52(7):1728-33. PubMed ID: 7521411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second-generation RIBA to confirm diagnosis of HCV infection.
    Lancet; 1991 Apr; 337(8746):912-3. PubMed ID: 1672986
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of Antibodies to HCV E1E2 by Lectin-Capture ELISA.
    Major M; Law M
    Methods Mol Biol; 2019; 1911():421-432. PubMed ID: 30593642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of NS3 and NS5 antigens in screening for HCV antibody.
    Goffin E; Pirson Y; Cornu C; Jadoul M; van Ypersele de Strihou C
    Lancet; 1994 Apr; 343(8901):854. PubMed ID: 7511196
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnostic and clinical implications of the different genotypes of hepatitis C virus.
    Bukh J; Miller RH
    Hepatology; 1994 Jul; 20(1 Pt 1):256-9. PubMed ID: 7517384
    [No Abstract]   [Full Text] [Related]  

  • 12. Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-3 protein.
    Nagayama R; Tsuda F; Okamoto H; Wang Y; Mitsui T; Tanaka T; Miyakawa Y; Mayumi M
    J Clin Invest; 1993 Sep; 92(3):1529-33. PubMed ID: 7690782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinguishing acute from symptomatic chronic hepatitis C virus (HCV) infection by site-directed serology of the HCV structural proteins.
    Zhang ZX; Chen M; Sönnerborg A; Weiland O; Sällberg M
    J Infect Dis; 1995 May; 171(5):1356-9. PubMed ID: 7538552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells.
    Rosa D; Campagnoli S; Moretto C; Guenzi E; Cousens L; Chin M; Dong C; Weiner AJ; Lau JY; Choo QL; Chien D; Pileri P; Houghton M; Abrignani S
    Proc Natl Acad Sci U S A; 1996 Mar; 93(5):1759-63. PubMed ID: 8700831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. A randomized controlled trial.
    Piazza M; Sagliocca L; Tosone G; Guadagnino V; Stazi MA; Orlando R; Borgia G; Rosa D; Abrignani S; Palumbo F; Manzin A; Clementi M
    Arch Intern Med; 1997 Jul; 157(14):1537-44. PubMed ID: 9236555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Liatek HCV: the six-antigen test for confirmation of the presence of anti-HCV antibodies].
    Juszczyk J; Flieger J; Migdalski P; Skalisz H
    Przegl Epidemiol; 1992; 46(1-2):11-7. PubMed ID: 1282266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatitis C virus and serologic tests for detection of viral hepatitis C].
    Bode JC; Alscher DM
    Med Klin (Munich); 1992 Oct; 87(10):527-31, 549. PubMed ID: 1334216
    [No Abstract]   [Full Text] [Related]  

  • 18. Predominance of antibodies to hepatitis C virus envelope proteins in various disease statuses of hepatitis C.
    PodurI CD; Khanna A; Khundmiri SJ; Khaja MN; Kumar KS; Sugunan VS; Habibullah CM; Das MR
    Acta Virol; 2001 Feb; 45(1):1-6. PubMed ID: 11394572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment.
    Zibert A; Schreier E; Roggendorf M
    Virology; 1995 Apr; 208(2):653-61. PubMed ID: 7538251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression, purification and immunogenic characterization of hepatitis C virus recombinant E1E2 protein expressed by Pichia pastoris yeast.
    Cai W; Su L; Liao Q; Ye L; Wu Y; Wu Z; She Y
    Antiviral Res; 2010 Oct; 88(1):80-5. PubMed ID: 20691736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.